Global and United States Clopidogrel Market Report & Forecast 2023-2028

Report ID: 1835382 | Published Date: Jan 2025 | No. of Page: 79 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Clopidogrel Product Introduction
    1.2 Global Clopidogrel Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Clopidogrel Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Clopidogrel Sales in Volume for the Year 2017-2028
    1.3 United States Clopidogrel Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Clopidogrel Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Clopidogrel Sales in Volume for the Year 2017-2028
    1.4 Clopidogrel Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Clopidogrel in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Clopidogrel Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Clopidogrel Market Dynamics
        1.5.1 Clopidogrel Industry Trends
        1.5.2 Clopidogrel Market Drivers
        1.5.3 Clopidogrel Market Challenges
        1.5.4 Clopidogrel Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Clopidogrel Market Segment by Type
        2.1.1 25mg
        2.1.2 75 mg
        2.1.3 300 mg
    2.2 Global Clopidogrel Market Size by Type
        2.2.1 Global Clopidogrel Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Clopidogrel Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Clopidogrel Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Clopidogrel Market Size by Type
        2.3.1 United States Clopidogrel Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Clopidogrel Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Clopidogrel Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Clopidogrel Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Private Clinics
        3.1.3 Retail Pharmacies
        3.1.4 Online Pharmacies
        3.1.5 Others
    3.2 Global Clopidogrel Market Size by Application
        3.2.1 Global Clopidogrel Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Clopidogrel Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Clopidogrel Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Clopidogrel Market Size by Application
        3.3.1 United States Clopidogrel Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Clopidogrel Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Clopidogrel Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Clopidogrel Competitor Landscape by Company
    4.1 Global Clopidogrel Market Size by Company
        4.1.1 Top Global Clopidogrel Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Clopidogrel Revenue by Manufacturer (2017-2022)
        4.1.3 Global Clopidogrel Sales by Manufacturer (2017-2022)
        4.1.4 Global Clopidogrel Price by Manufacturer (2017-2022)
    4.2 Global Clopidogrel Concentration Ratio (CR)
        4.2.1 Clopidogrel Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Clopidogrel in 2021
        4.2.3 Global Clopidogrel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Clopidogrel Manufacturing Base Distribution, Product Type
        4.3.1 Global Clopidogrel Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Clopidogrel Product Type
        4.3.3 Date of International Manufacturers Enter into Clopidogrel Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Clopidogrel Market Size by Company
        4.5.1 Top Clopidogrel Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Clopidogrel Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Clopidogrel Sales by Players (2020, 2021 & 2022)
5 Global Clopidogrel Market Size by Region
    5.1 Global Clopidogrel Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Clopidogrel Market Size in Volume by Region (2017-2028)
        5.2.1 Global Clopidogrel Sales in Volume by Region: 2017-2022
        5.2.2 Global Clopidogrel Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Clopidogrel Market Size in Value by Region (2017-2028)
        5.3.1 Global Clopidogrel Sales in Value by Region: 2017-2022
        5.3.2 Global Clopidogrel Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Clopidogrel Market Size YoY Growth 2017-2028
        6.1.2 North America Clopidogrel Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Clopidogrel Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Clopidogrel Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Clopidogrel Market Size YoY Growth 2017-2028
        6.3.2 Europe Clopidogrel Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Clopidogrel Market Size YoY Growth 2017-2028
        6.4.2 Latin America Clopidogrel Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Clopidogrel Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Clopidogrel Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Sanofi (France)
        7.1.1 Sanofi (France) Corporation Information
        7.1.2 Sanofi (France) Description and Business Overview
        7.1.3 Sanofi (France) Clopidogrel Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Sanofi (France) Clopidogrel Products Offered
        7.1.5 Sanofi (France) Recent Development
    7.2 Shenzhen Salubris Pharmaceuticals (China)
        7.2.1 Shenzhen Salubris Pharmaceuticals (China) Corporation Information
        7.2.2 Shenzhen Salubris Pharmaceuticals (China) Description and Business Overview
        7.2.3 Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Products Offered
        7.2.5 Shenzhen Salubris Pharmaceuticals (China) Recent Development
    7.3 Lepu Medical Technology (China)
        7.3.1 Lepu Medical Technology (China) Corporation Information
        7.3.2 Lepu Medical Technology (China) Description and Business Overview
        7.3.3 Lepu Medical Technology (China) Clopidogrel Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Lepu Medical Technology (China) Clopidogrel Products Offered
        7.3.5 Lepu Medical Technology (China) Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Clopidogrel Industry Chain Analysis
    8.2 Clopidogrel Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Clopidogrel Distributors
    8.3 Clopidogrel Production Mode & Process
    8.4 Clopidogrel Sales and Marketing
        8.4.1 Clopidogrel Sales Channels
        8.4.2 Clopidogrel Distributors
    8.5 Clopidogrel Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Clopidogrel CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Clopidogrel Market Trends
    Table 3. Clopidogrel Market Drivers
    Table 4. Clopidogrel Market Challenges
    Table 5. Clopidogrel Market Restraints
    Table 6. Global Clopidogrel Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Clopidogrel Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Clopidogrel Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Clopidogrel Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Clopidogrel Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Clopidogrel Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Clopidogrel Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Clopidogrel Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Clopidogrel Sales Share by Manufacturer, 2017-2022
    Table 15. Global Clopidogrel Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Clopidogrel Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Clopidogrel by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clopidogrel as of 2021)
    Table 18. Top Players of Clopidogrel in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Clopidogrel Product Type
    Table 20. Date of International Manufacturers Enter into Clopidogrel Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Clopidogrel Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Clopidogrel Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Clopidogrel Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Clopidogrel Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Clopidogrel Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Clopidogrel Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Clopidogrel Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Clopidogrel Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Clopidogrel Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Clopidogrel Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Clopidogrel Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Clopidogrel Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Clopidogrel Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Clopidogrel Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Clopidogrel Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Clopidogrel Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Clopidogrel Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Clopidogrel Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Clopidogrel Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Clopidogrel Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Sanofi (France) Corporation Information
    Table 43. Sanofi (France) Description and Business Overview
    Table 44. Sanofi (France) Clopidogrel Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Sanofi (France) Clopidogrel Product
    Table 46. Sanofi (France) Recent Development
    Table 47. Shenzhen Salubris Pharmaceuticals (China) Corporation Information
    Table 48. Shenzhen Salubris Pharmaceuticals (China) Description and Business Overview
    Table 49. Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Shenzhen Salubris Pharmaceuticals (China) Product
    Table 51. Shenzhen Salubris Pharmaceuticals (China) Recent Development
    Table 52. Lepu Medical Technology (China) Corporation Information
    Table 53. Lepu Medical Technology (China) Description and Business Overview
    Table 54. Lepu Medical Technology (China) Clopidogrel Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Lepu Medical Technology (China) Product
    Table 56. Lepu Medical Technology (China) Recent Development
    Table 57. Key Raw Materials Lists
    Table 58. Raw Materials Key Suppliers Lists
    Table 59. Clopidogrel Customers List
    Table 60. Clopidogrel Distributors List
    Table 61. Research Programs/Design for This Report
    Table 62. Key Data Information from Secondary Sources
    Table 63. Key Data Information from Primary Sources
List of Figures
    Figure 1. Clopidogrel Product Picture
    Figure 2. Global Clopidogrel Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Clopidogrel Market Size 2017-2028 (US$ Million)
    Figure 4. Global Clopidogrel Sales 2017-2028 (K Units)
    Figure 5. United States Clopidogrel Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Clopidogrel Market Size 2017-2028 (US$ Million)
    Figure 7. United States Clopidogrel Sales 2017-2028 (K Units)
    Figure 8. United States Clopidogrel Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Clopidogrel Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Clopidogrel Report Years Considered
    Figure 11. Product Picture of 25mg
    Figure 12. Product Picture of 75 mg
    Figure 13. Product Picture of 300 mg
    Figure 14. Global Clopidogrel Market Share by Type in 2022 & 2028
    Figure 15. Global Clopidogrel Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Clopidogrel Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Clopidogrel Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Clopidogrel Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Clopidogrel Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Clopidogrel Market Share by Type in 2022 & 2028
    Figure 21. United States Clopidogrel Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Clopidogrel Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Clopidogrel Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Clopidogrel Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Clopidogrel Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Private Clinics
    Figure 28. Product Picture of Retail Pharmacies
    Figure 29. Product Picture of Online Pharmacies
    Figure 30. Product Picture of Others
    Figure 31. Global Clopidogrel Market Share by Application in 2022 & 2028
    Figure 32. Global Clopidogrel Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Clopidogrel Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Clopidogrel Sales by Application (2017-2028) & (K Units)
    Figure 35. Global Clopidogrel Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Clopidogrel Price by Application (2017-2028) & (USD/Unit)
    Figure 37. United States Clopidogrel Market Share by Application in 2022 & 2028
    Figure 38. United States Clopidogrel Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Clopidogrel Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Clopidogrel Sales by Application (2017-2028) & (K Units)
    Figure 41. United States Clopidogrel Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Clopidogrel Price by Application (2017-2028) & (USD/Unit)
    Figure 43. North America Clopidogrel Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. North America Clopidogrel Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Clopidogrel Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Clopidogrel Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Clopidogrel Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Clopidogrel Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Clopidogrel Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Clopidogrel Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Clopidogrel Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Clopidogrel Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. UAE Clopidogrel Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Clopidogrel Value Chain
    Figure 77. Clopidogrel Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi (France)
Shenzhen Salubris Pharmaceuticals (China)
Lepu Medical Technology (China)
Frequently Asked Questions
Clopidogrel report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Clopidogrel report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Clopidogrel report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports